<DOC>
	<DOCNO>NCT01269970</DOCNO>
	<brief_summary>Early metabolic response evaluation may predict clinical histopathological response neoadjuvant chemotherapy . Its value neoadjuvant chemoradiotherapy ( CRT ) unknown . Our aim ass value early metabolic response one cycle chemotherapy use 18-FDG-PET-CT predict pathological response outcome cT2-4 N0/+ esophageal cancer treat neoadjuvant CRT esophagectomy .</brief_summary>
	<brief_title>Early Metabolic Response Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>locally advanced esophageal cancer ( cT24 N0/+ ) PETCT perform UZLeuven Other tumor type Distant metastasis ( organ )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>